Modifi Biosciences announced that it has been acquired by global pharmaceutical giant Merck, with a $30 million down payment.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Data from two promising vaccine trials heralded potential breakthroughs in the treatment of pneumococcal infection and Lyme disease.
The company announced positive results in an early-stage trial of the individualized cancer vaccine it developed with Merck.
Some of pharma’s biggest players — including Merck, Amgen, Abbvie, and Gilead — formed an alliance to fight looming M&A reforms.